Isidore Tiandiogo Traoré
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Isidore Tiandiogo Traoré has a total of 149 co-authors. Here are the top co-authors by number of shared publications:
- Caroline Gilbert
Axe de Recherche Maladies Infectieuses et Immunitaires Centre de Recherche du CHU de Québec‐Université Laval Québec Canada
3 shared publications - Cheick Ahmed Ouattara
Agence de Formation de Recherche et d’Expertise en Santé pour l’Afrique (AFRICSanté), Bobo-Dioulasso 01 BP 298, Burkina Faso
3 shared publications - Dramane Kania
Centre Muraz, Bobo-Dioulasso, Burkina Faso
3 shared publications - Ibrahim Sangaré
Centre d’Excellence Africain en Innovations Biotechnologiques pour l’Elimination des Maladies à Transmission Vectorielle (CEA/ITECH-MTV), Université Nazi Boni, Bobo-Dioulasso 01 BP 1091, Burkina Faso
3 shared publications - Léon Gueswendé Blaise Savadogo
Université Nazi Boni, Institut supérieur des sciences de la santé (INSSA), Burkina Faso
3 shared publications - Nongodo Firmin Kaboré
Centre Muraz, Bobo-Dioulasso, Burkina Faso
3 shared publications
Latest Publications
- Open Access
SARS-CoV-2 Antibody Response during Omicron Predominance after COVID-19 Vaccination in People Living with HIV: A Comparative Study in Canada and Burkina Faso
People living with HIV (PLWH) are known to maintain a degree of immune deficiency despite efficient antiretroviral therapy and may exhibit diminished responses to vaccines. In this study, we assessed the immune response to SARS-CoV-2 infection and vaccines in two geographically distinct PLWH populations. PLWH and HIV-negative (HIV-) participants were recruited from Quebec City (QC), Canada, and Bobo-Dioulasso (BD), Burkina Faso, for two visits at 24-week intervals during the predominance of the Omicron variant, from May 2022 to September 2023. Blood samples were collected at each visit for the detection of antibodies against spike (anti-S) and nucleocapsid (anti-N) proteins of SARS-CoV-2 in platelet-free plasma. A total of 360 participants were enrolled. We detected anti-S antibodies in 99% of participants, indicating that nearly all had prior exposure to the SARS-CoV-2 spike antigen, either through vaccination or prior infection. Anti-S titers showed no difference between PLWH and HIV-participants in each location, while significantly higher titers were observed in participants from QC compared to BD. In contrast, anti-N antibodies, indicative of prior infection, were detected in 39% and 86% of the participants in QC and BD, respectively, suggesting that the virus circulated largely in the latter population. No difference in anti-N levels was observed between PLWH and HIV-participants in BD. However, participants in QC had significantly lower titers compared to HIV-participants. Overall, this study shows that PLWH develop robust antibody responses to SARS-CoV-2 vaccination, comparable to those observed in HIV-participants. Significant geographic differences were observed in anti-S titers, irrespective of HIV status, with participants from QC displaying higher titers. In contrast, participants from BD had higher anti-N antibody prevalence and titers, reflecting more SARS-CoV-2 infections in BD than in QC. Finally, analysis of anti-S antibody titers against several circulating variants revealed significantly lower levels in unvaccinated participants and in those vaccinated with monovalent vaccines in BD. No significant difference was observed between monovalent and bivalent vaccines administered in QC.
Open AccessSARS-CoV-2 Antibody Response during Omicron Predominance after COVID-19 Vaccination in People Living with HIV: A Comparative Study in Canada and Burkina Faso
People living with HIV (PLWH) are known to maintain a degree of immune deficiency despite efficient antiretroviral therapy and may exhibit diminished responses to vaccines. In this study, we assessed the immune response to SARS-CoV-2 infection and vaccines in two geographically distinct PLWH populations. PLWH and HIV-negative (HIV-) participants were recruited from Quebec City (QC), Canada, and Bobo-Dioulasso (BD), Burkina Faso, for two visits at 24-week intervals during the predominance of the Omicron variant, from May 2022 to September 2023. Blood samples were collected at each visit for the detection of antibodies against spike (anti-S) and nucleocapsid (anti-N) proteins of SARS-CoV-2 in platelet-free plasma. A total of 360 participants were enrolled. We detected anti-S antibodies in 99% of participants, indicating that nearly all had prior exposure to the SARS-CoV-2 spike antigen, either through vaccination or prior infection. Anti-S titers showed no difference between PLWH and HIV-participants in each location, while significantly higher titers were observed in participants from QC compared to BD. In contrast, anti-N antibodies, indicative of prior infection, were detected in 39% and 86% of the participants in QC and BD, respectively, suggesting that the virus circulated largely in the latter population. No difference in anti-N levels was observed between PLWH and HIV-participants in BD. However, participants in QC had significantly lower titers compared to HIV-participants. Overall, this study shows that PLWH develop robust antibody responses to SARS-CoV-2 vaccination, comparable to those observed in HIV-participants. Significant geographic differences were observed in anti-S titers, irrespective of HIV status, with participants from QC displaying higher titers. In contrast, participants from BD had higher anti-N antibody prevalence and titers, reflecting more SARS-CoV-2 infections in BD than in QC. Finally, analysis of anti-S antibody titers against several circulating variants revealed significantly lower levels in unvaccinated participants and in those vaccinated with monovalent vaccines in BD. No significant difference was observed between monovalent and bivalent vaccines administered in QC.
- Open Access
- 1 January 2026
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 17 (1)
An automated machine learning approach to predict glycaemic control in patients with type 2 diabetes in Burkina Faso
Background: Machine learning offers opportunities to improve risk stratification in type 2 diabetes by capturing complex clinical and sociodemographic interactions. Aim: To develop and evaluate machine learning models for predicting 1-year glycaemic control in patients with type 2 diabetes in Burkina Faso. Setting: A tertiary hospital in Burkina Faso, including patients followed up between 2020 and 2025. Methods: A retrospective cohort study included 424 patients. Glycaemic control was defined as glycated haemoglobin (HbA1c) < 7% at 1 year. Nine classifiers were trained using nested cross-validation. Performance was assessed using AUC-ROC, F1-score, recall, accuracy, precision and AUC-PR. Interpretability was assessed using SHAP (SHapley Additive exPlanations) with consensus feature importance ranking. Results: Overall, 42.9% of patients achieved glycaemic control at 1 year. Performance was moderate, with AUC-ROC ranging from 0.633 to 0.676 and no significant pairwise differences. AdaBoost performed best (AUC-ROC: 0.676). SHAP consistently identified baseline HbA1c, diabetes duration, total cholesterol, hypertension history and oral antidiabetic therapy as the most influential predictors. Conclusion: Machine learning models showed moderate, comparable performance, suggesting a ceiling imposed by routinely available data. Baseline HbA1c and diabetes duration were dominant predictors. Future research should prioritise external validation and longitudinal data integration. Contribution: This study provides evidence supporting machine learning for identifying key predictors of glycaemic control in West Africa, offering clinically actionable insights and highlighting the need for context-adapted decision-support tools in resource-limited settings.
- 1 January 2026
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 17 (1)
Open AccessAn automated machine learning approach to predict glycaemic control in patients with type 2 diabetes in Burkina Faso
Background: Machine learning offers opportunities to improve risk stratification in type 2 diabetes by capturing complex clinical and sociodemographic interactions. Aim: To develop and evaluate machine learning models for predicting 1-year glycaemic control in patients with type 2 diabetes in Burkina Faso. Setting: A tertiary hospital in Burkina Faso, including patients followed up between 2020 and 2025. Methods: A retrospective cohort study included 424 patients. Glycaemic control was defined as glycated haemoglobin (HbA1c) < 7% at 1 year. Nine classifiers were trained using nested cross-validation. Performance was assessed using AUC-ROC, F1-score, recall, accuracy, precision and AUC-PR. Interpretability was assessed using SHAP (SHapley Additive exPlanations) with consensus feature importance ranking. Results: Overall, 42.9% of patients achieved glycaemic control at 1 year. Performance was moderate, with AUC-ROC ranging from 0.633 to 0.676 and no significant pairwise differences. AdaBoost performed best (AUC-ROC: 0.676). SHAP consistently identified baseline HbA1c, diabetes duration, total cholesterol, hypertension history and oral antidiabetic therapy as the most influential predictors. Conclusion: Machine learning models showed moderate, comparable performance, suggesting a ceiling imposed by routinely available data. Baseline HbA1c and diabetes duration were dominant predictors. Future research should prioritise external validation and longitudinal data integration. Contribution: This study provides evidence supporting machine learning for identifying key predictors of glycaemic control in West Africa, offering clinically actionable insights and highlighting the need for context-adapted decision-support tools in resource-limited settings.
- Open Access
- 1 January 2026
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 17 (1)
Knowledge, attitudes, and practices of Tougan population towards dengue in Burkina Faso in 2024
Background: Recent dengue outbreaks in Burkina Faso have caused substantial morbidity and mortality among semi-urban and urban populations. Aim: To assess the knowledge, attitudes, and practices (KAP) among the population of Tougan, a semi-urban city, towards dengue. Setting: Between April 2024 and July 2024, a cross-sectional study was performed among residents and internally displaced populations (IDPs) in Tougan. Methods: Participants aged 18 years and older, recruited through an adapted three-stage random sampling were eligible. Sociodemographic data as well as information on knowledge, attitudes, and practices (KAP) were collected using a questionnaire. Factors associated with good knowledge of dengue (i.e. knowledge score ≥ 11) were identified using logistic regression models. Results: A total of 419 participants, including 130 (31.1%) IDPs, were enrolled in the study. The majority were male (53.9%), with a mean age of 38.5 years (standard deviation [s.d.] 12.9). The mean scores of KAP regarding dengue were 10.1 (s.d. 1.2), 13.5 (s.d. 1.9), and 9.4 (s.d. 2.2), respectively. Internally displaced populations had significantly lower levels of knowledge of dengue (adjusted odds ratio [aOR]: 0.49, 95% confidence interval [CI]: 0.29–0.81, p = 0.006) compared to residents. Moreover, participants with stagnant water at their home (aOR: 3.03, 95% CI: 1.84–4.96, p < 0.001) and those with good practices towards dengue (aOR: 3.39, 95% CI: 1.37–8.38, p = 0.008) had better knowledge. Conclusion: Context-specific prevention messages on dengue and targeted interventions should be developed for IDPs and residents from semi-urban areas in Burkina Faso. Contribution: This study provides findings to enhance dengue awareness among vulnerable populations and preparedness for future epidemics.
- 1 January 2026
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 17 (1)
Open AccessKnowledge, attitudes, and practices of Tougan population towards dengue in Burkina Faso in 2024
Background: Recent dengue outbreaks in Burkina Faso have caused substantial morbidity and mortality among semi-urban and urban populations. Aim: To assess the knowledge, attitudes, and practices (KAP) among the population of Tougan, a semi-urban city, towards dengue. Setting: Between April 2024 and July 2024, a cross-sectional study was performed among residents and internally displaced populations (IDPs) in Tougan. Methods: Participants aged 18 years and older, recruited through an adapted three-stage random sampling were eligible. Sociodemographic data as well as information on knowledge, attitudes, and practices (KAP) were collected using a questionnaire. Factors associated with good knowledge of dengue (i.e. knowledge score ≥ 11) were identified using logistic regression models. Results: A total of 419 participants, including 130 (31.1%) IDPs, were enrolled in the study. The majority were male (53.9%), with a mean age of 38.5 years (standard deviation [s.d.] 12.9). The mean scores of KAP regarding dengue were 10.1 (s.d. 1.2), 13.5 (s.d. 1.9), and 9.4 (s.d. 2.2), respectively. Internally displaced populations had significantly lower levels of knowledge of dengue (adjusted odds ratio [aOR]: 0.49, 95% confidence interval [CI]: 0.29–0.81, p = 0.006) compared to residents. Moreover, participants with stagnant water at their home (aOR: 3.03, 95% CI: 1.84–4.96, p < 0.001) and those with good practices towards dengue (aOR: 3.39, 95% CI: 1.37–8.38, p = 0.008) had better knowledge. Conclusion: Context-specific prevention messages on dengue and targeted interventions should be developed for IDPs and residents from semi-urban areas in Burkina Faso. Contribution: This study provides findings to enhance dengue awareness among vulnerable populations and preparedness for future epidemics.
- Open Access
- 9 July 2025
- Published by Science Publishing Group in Science Journal of Public Health
- Vol. 13 (4) , 177-188
Superiority of Three Directly Observed Treatment Compared to One Directly Observed Treatment in the Seasonal Malaria Chemoprevention in Children Aged Under Five in Burkina Faso: A Quasi-Experimental Trial
The implementation of seasonal malaria chemoprevention (SMC) in Burkina Faso has not achieved its objective of reducing by at least 60% the morbidity associated with malaria in children under 5 years of age. We assessed a new approach of delivery consisting for the community health workers to directly supervise the three doses of the treatment compared to the standard of delivery (only the first dose directly observed treatment). The objective of the study was to compare the superiority of three doses supervised intake of SMC (3DOT) to the supervised intake of the first dose only. Three centers for health and social promotion were randomly selected in the Gaoua health district (3DOT) and 4 in the Boromo health district (1DOT) to receive a monthly four rounds of SMC with Sulfadoxine-pyrimethamine plus Amodiaquine (SP+AQ) in a quasi-experimental cluster randomized trial, before-after with a control group design which included in total 2440 children. The primary endpoint was the reduction in prevalence between each SMC round. The Khi-2 test was used to assess the superiority of 3DOT versus 1DOT. The reduction of malaria prevalence was significantly higher in 3DOT compared to the 1DOT, 68.60% vs 53.00% (p<.0001). The coverage in the 3DOT was significantly lower than that in the 1DOT, 81.39% versus 95.72%; p<0.0001 for optimal coverage. The 3DOT delivery approach of SMC provides better reduction of malaria prevalence than the 1DOT. However, the lower coverage obtained with the 3DOT compared to the 1DOT is a concerning issue to overcome in the perspective of the scale-up of this strategy at large scale.
- 9 July 2025
- Published by Science Publishing Group in Science Journal of Public Health
- Vol. 13 (4) , 177-188
Open AccessSuperiority of Three Directly Observed Treatment Compared to One Directly Observed Treatment in the Seasonal Malaria Chemoprevention in Children Aged Under Five in Burkina Faso: A Quasi-Experimental Trial
The implementation of seasonal malaria chemoprevention (SMC) in Burkina Faso has not achieved its objective of reducing by at least 60% the morbidity associated with malaria in children under 5 years of age. We assessed a new approach of delivery consisting for the community health workers to directly supervise the three doses of the treatment compared to the standard of delivery (only the first dose directly observed treatment). The objective of the study was to compare the superiority of three doses supervised intake of SMC (3DOT) to the supervised intake of the first dose only. Three centers for health and social promotion were randomly selected in the Gaoua health district (3DOT) and 4 in the Boromo health district (1DOT) to receive a monthly four rounds of SMC with Sulfadoxine-pyrimethamine plus Amodiaquine (SP+AQ) in a quasi-experimental cluster randomized trial, before-after with a control group design which included in total 2440 children. The primary endpoint was the reduction in prevalence between each SMC round. The Khi-2 test was used to assess the superiority of 3DOT versus 1DOT. The reduction of malaria prevalence was significantly higher in 3DOT compared to the 1DOT, 68.60% vs 53.00% (p<.0001). The coverage in the 3DOT was significantly lower than that in the 1DOT, 81.39% versus 95.72%; p<0.0001 for optimal coverage. The 3DOT delivery approach of SMC provides better reduction of malaria prevalence than the 1DOT. However, the lower coverage obtained with the 3DOT compared to the 1DOT is a concerning issue to overcome in the perspective of the scale-up of this strategy at large scale.
- Open Access
- 12 January 2024
- Published by Veterinary World in International Journal of One Health
Detection and molecular characterization of multiresistant Enterobacteriaceae carried by houseflies in the city of Bobo-Dioulasso, Burkina Faso
The aim of this study was to detect and characterize multidrug-resistant Enterobacteriaceae carried by houseflies in Bobo-Dioulasso.
- 12 January 2024
- Published by Veterinary World in International Journal of One Health
Open AccessDetection and molecular characterization of multiresistant Enterobacteriaceae carried by houseflies in the city of Bobo-Dioulasso, Burkina Faso
The aim of this study was to detect and characterize multidrug-resistant Enterobacteriaceae carried by houseflies in Bobo-Dioulasso.
- Open Access
- 3 January 2024
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 110 (1) , 170-178
A Qualitative Study of the Experience of COVID-19 Patients in Burkina Faso
In Burkina Faso, the health system is characterized by systemic insufficient and antiquated health-care infrastructures. Consequently, few health-care establishments have the required resources to diagnose and manage patients with COVID-19, and fewer still have intensive care facilities for severely ill patients with COVID. Furthermore, there is a widespread scarcity of qualified health-care staff. The aim of this study was to explore the experiences of patients with COVID-19 who recovered after being cared for in Bobo Dioulasso and Ouagadougou. Using individual semistructured interviews, we performed a cross-sectional qualitative, descriptive study from June 12 to 30, 2020 with the aid of 13 well-educated patients who had survived COVID-19. The results reveal that prior to hospital admission, the main reason that prompted patients to seek care was onset of symptoms of COVID-19, regardless of whether they had been in contact with suspected or confirmed cases. Transmission was mainly believed to have occurred in the community, in the hospital, and during travel. Patient management was punctuated by frequent self-medication with medicinal plants or pharmaceutical drugs. The participants reported a negative perception of hospitalization or home-based management, with several forms of stigmatization, but a positive perception influenced by the satisfactory quality of management in health-care centers. This report of patient experiences could be helpful in improving the management of COVID-19 in Burkina Faso, both in the health-care setting and in home-based care.
- 3 January 2024
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 110 (1) , 170-178
Open AccessA Qualitative Study of the Experience of COVID-19 Patients in Burkina Faso
In Burkina Faso, the health system is characterized by systemic insufficient and antiquated health-care infrastructures. Consequently, few health-care establishments have the required resources to diagnose and manage patients with COVID-19, and fewer still have intensive care facilities for severely ill patients with COVID. Furthermore, there is a widespread scarcity of qualified health-care staff. The aim of this study was to explore the experiences of patients with COVID-19 who recovered after being cared for in Bobo Dioulasso and Ouagadougou. Using individual semistructured interviews, we performed a cross-sectional qualitative, descriptive study from June 12 to 30, 2020 with the aid of 13 well-educated patients who had survived COVID-19. The results reveal that prior to hospital admission, the main reason that prompted patients to seek care was onset of symptoms of COVID-19, regardless of whether they had been in contact with suspected or confirmed cases. Transmission was mainly believed to have occurred in the community, in the hospital, and during travel. Patient management was punctuated by frequent self-medication with medicinal plants or pharmaceutical drugs. The participants reported a negative perception of hospitalization or home-based management, with several forms of stigmatization, but a positive perception influenced by the satisfactory quality of management in health-care centers. This report of patient experiences could be helpful in improving the management of COVID-19 in Burkina Faso, both in the health-care setting and in home-based care.
- Open Access
- 25 October 2023
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 8 (11) , 482
Spatio-Temporal Determinants of Dengue Epidemics in the Central Region of Burkina Faso
The aim of this study was to analyze the spatio-temporal distribution and determinants of the 2017 dengue epidemic in Burkina Faso. A principal component analysis of meteorological and environmental factors was performed to reduce dimensions and avoid collinearities. An initial generalized additive model assessed the impact of the components derived from this analysis on dengue incidence. Dengue incidence increased mainly with relative humidity, precipitation, normalized difference vegetation index and minimum temperature with an 8-week lag. A Kulldoff Satscan scan was used to identify high-risk dengue clusters, and a second generalized additive model assessed the risk of a health area being at high risk according to land-use factors. The spatio-temporal distribution of dengue fever was heterogeneous and strongly correlated with meteorological factors. The rural communes of Sabaa and Koubri were the areas most at risk. This study provides useful information for planning targeted dengue control strategies in Burkina Faso.
- 25 October 2023
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 8 (11) , 482
Open AccessSpatio-Temporal Determinants of Dengue Epidemics in the Central Region of Burkina Faso
The aim of this study was to analyze the spatio-temporal distribution and determinants of the 2017 dengue epidemic in Burkina Faso. A principal component analysis of meteorological and environmental factors was performed to reduce dimensions and avoid collinearities. An initial generalized additive model assessed the impact of the components derived from this analysis on dengue incidence. Dengue incidence increased mainly with relative humidity, precipitation, normalized difference vegetation index and minimum temperature with an 8-week lag. A Kulldoff Satscan scan was used to identify high-risk dengue clusters, and a second generalized additive model assessed the risk of a health area being at high risk according to land-use factors. The spatio-temporal distribution of dengue fever was heterogeneous and strongly correlated with meteorological factors. The rural communes of Sabaa and Koubri were the areas most at risk. This study provides useful information for planning targeted dengue control strategies in Burkina Faso.
- Open Access
- 12 June 2023
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 23 (1) , 1-11
Incidence rate and predictors of COVID-19 in the two largest cities of Burkina Faso - prospective cohort study in 2021 (ANRS-COV13)
Background: Early data on COVID-19 (based primarily on PCR testing) indicated a low burden in Sub-Saharan Africa. To better understand this, this study aimed to estimate the incidence rate and identify predictors of SARS-CoV-2 seroconversion in the two largest cities of Burkina Faso. This study is part of the EmulCOVID-19 project (ANRS-COV13). Methods: Our study utilized the WHO Unity protocol for cohort sero-epidemiological studies of COVID-19 in general population. We conducted random sampling stratified by age group and sex. Individuals aged 10 years and older in the cities of Ouagadougou and Bobo-Dioulasso, Burkina Faso were included and surveyed at 4 time points, each 21 days apart, from March 3 to May 15, 2021. WANTAI SARS-CoV-2 Ab ELISA serological tests were used to detect total antibodies (IgM, IgG) in serum. Predictors were investigated using Cox proportional hazards regression. Results: We analyzed the data from 1399 participants (1051 in Ouagadougou, 348 in Bobo-Dioulasso) who were SARS-CoV-2 seronegative at baseline and had at least one follow-up visit. The incidence rate of SARS-CoV-2 seroconversion was 14.3 cases [95%CI 13.3–15.4] per 100 person-weeks. The incidence rate was almost three times higher in Ouagadougou than in Bobo-Dioulasso (Incidence rate ratio: IRR = 2.7 [2.2–3.2], p < 0.001). The highest incidence rate was reported among women aged 19–59 years in Ouagadougou (22.8 cases [19.6–26.4] per 100 person-weeks) and the lowest among participants aged 60 years and over in Bobo-Dioulasso, 6.3 cases [4.6–8.6] per 100 person-weeks. Multivariable analysis showed that participants aged 19 years and older were almost twice as likely to seroconvert during the study period compared with those aged 10 to 18 years (Hazard ratio: HR = 1.7 [1.3–2.3], p < 0.001). Those aged 10–18 years exhibited more asymptomatic forms than those aged 19 years and older, among those who achieved seroconversion (72.9% vs. 40.4%, p < 0.001). Conclusion: The spread of COVID-19 is more rapid in adults and in large cities. Strategies to control this pandemic in Burkina Faso, must take this into account. Adults living in large cities should be the priority targets for vaccination efforts against COVID-19.
- 12 June 2023
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 23 (1) , 1-11
Open AccessIncidence rate and predictors of COVID-19 in the two largest cities of Burkina Faso - prospective cohort study in 2021 (ANRS-COV13)
Background: Early data on COVID-19 (based primarily on PCR testing) indicated a low burden in Sub-Saharan Africa. To better understand this, this study aimed to estimate the incidence rate and identify predictors of SARS-CoV-2 seroconversion in the two largest cities of Burkina Faso. This study is part of the EmulCOVID-19 project (ANRS-COV13). Methods: Our study utilized the WHO Unity protocol for cohort sero-epidemiological studies of COVID-19 in general population. We conducted random sampling stratified by age group and sex. Individuals aged 10 years and older in the cities of Ouagadougou and Bobo-Dioulasso, Burkina Faso were included and surveyed at 4 time points, each 21 days apart, from March 3 to May 15, 2021. WANTAI SARS-CoV-2 Ab ELISA serological tests were used to detect total antibodies (IgM, IgG) in serum. Predictors were investigated using Cox proportional hazards regression. Results: We analyzed the data from 1399 participants (1051 in Ouagadougou, 348 in Bobo-Dioulasso) who were SARS-CoV-2 seronegative at baseline and had at least one follow-up visit. The incidence rate of SARS-CoV-2 seroconversion was 14.3 cases [95%CI 13.3–15.4] per 100 person-weeks. The incidence rate was almost three times higher in Ouagadougou than in Bobo-Dioulasso (Incidence rate ratio: IRR = 2.7 [2.2–3.2], p < 0.001). The highest incidence rate was reported among women aged 19–59 years in Ouagadougou (22.8 cases [19.6–26.4] per 100 person-weeks) and the lowest among participants aged 60 years and over in Bobo-Dioulasso, 6.3 cases [4.6–8.6] per 100 person-weeks. Multivariable analysis showed that participants aged 19 years and older were almost twice as likely to seroconvert during the study period compared with those aged 10 to 18 years (Hazard ratio: HR = 1.7 [1.3–2.3], p < 0.001). Those aged 10–18 years exhibited more asymptomatic forms than those aged 19 years and older, among those who achieved seroconversion (72.9% vs. 40.4%, p < 0.001). Conclusion: The spread of COVID-19 is more rapid in adults and in large cities. Strategies to control this pandemic in Burkina Faso, must take this into account. Adults living in large cities should be the priority targets for vaccination efforts against COVID-19.
- Open Access
- 18 January 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (3) , 1924
HIV Replication Increases the Mitochondrial DNA Content of Plasma Extracellular Vesicles
Extracellular vesicles (EVs) and their cargo have been studied intensively as potential sources of biomarkers in HIV infection; however, their DNA content, particularly the mitochondrial portion (mtDNA), remains largely unexplored. It is well known that human immunodeficiency virus (HIV) infection and prolonged antiretroviral therapy (ART) lead to mitochondrial dysfunction and reduced mtDNA copy in cells and tissues. Moreover, mtDNA is a well-known damage-associated molecular pattern molecule that could potentially contribute to increased immune activation, oxidative stress, and inflammatory response. We investigated the mtDNA content of large and small plasma EVs in persons living with HIV (PLWH) and its implications for viral replication, ART use, and immune status. Venous blood was collected from 196 PLWH, ART-treated or ART-naïve (66 with ongoing viral replication, ≥20 copies/mL), and from 53 HIV-negative persons, all recruited at five HIV testing or treatment centers in Burkina Faso. Large and small plasma EVs were purified and counted, and mtDNA level was measured by RT-qPCR. Regardless of HIV status, mtDNA was more abundant in large than small EVs. It was more abundant in EVs of viremic than aviremic and control participants and tended to be more abundant in participants treated with Tenofovir compared with Zidovudine. When ART treatment was longer than six months and viremia was undetectable, no variation in EV mtDNA content versus CD4 and CD8 count or CD4/CD8 ratio was observed. However, mtDNA in large and small EVs decreased with years of HIV infection and ART. Our results highlight the impact of viral replication and ART on large and small EVs’ mtDNA content. The mechanisms underlying the differential incorporation of mtDNA into EVs and their effects on the surrounding cells warrant further investigation.
- 18 January 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (3) , 1924
Open AccessHIV Replication Increases the Mitochondrial DNA Content of Plasma Extracellular Vesicles
Extracellular vesicles (EVs) and their cargo have been studied intensively as potential sources of biomarkers in HIV infection; however, their DNA content, particularly the mitochondrial portion (mtDNA), remains largely unexplored. It is well known that human immunodeficiency virus (HIV) infection and prolonged antiretroviral therapy (ART) lead to mitochondrial dysfunction and reduced mtDNA copy in cells and tissues. Moreover, mtDNA is a well-known damage-associated molecular pattern molecule that could potentially contribute to increased immune activation, oxidative stress, and inflammatory response. We investigated the mtDNA content of large and small plasma EVs in persons living with HIV (PLWH) and its implications for viral replication, ART use, and immune status. Venous blood was collected from 196 PLWH, ART-treated or ART-naïve (66 with ongoing viral replication, ≥20 copies/mL), and from 53 HIV-negative persons, all recruited at five HIV testing or treatment centers in Burkina Faso. Large and small plasma EVs were purified and counted, and mtDNA level was measured by RT-qPCR. Regardless of HIV status, mtDNA was more abundant in large than small EVs. It was more abundant in EVs of viremic than aviremic and control participants and tended to be more abundant in participants treated with Tenofovir compared with Zidovudine. When ART treatment was longer than six months and viremia was undetectable, no variation in EV mtDNA content versus CD4 and CD8 count or CD4/CD8 ratio was observed. However, mtDNA in large and small EVs decreased with years of HIV infection and ART. Our results highlight the impact of viral replication and ART on large and small EVs’ mtDNA content. The mechanisms underlying the differential incorporation of mtDNA into EVs and their effects on the surrounding cells warrant further investigation.
- Open Access
- 9 September 2022
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 7 (9) , 237
Delays in TB Diagnosis and Treatment Initiation in Burkina Faso during the COVID-19 Pandemic
The COVID-19 pandemic has significantly disrupted TB services, particularly in low resource settings. In Burkina Faso, a cross-sectional ‘before and after’ study was conducted to assess the impact of COVID-19 on access to TB services. Data was collected in two phases (Phase 1: December 2017–March 2018, and 2: October–December 2020) to estimate and compare various patient and system delays among TB patients before and during COVID-19 and explore changes in treatment seeking behaviors and practices. 331 TB patients were recruited across the two phases. A significant increase in median time between first symptom and contact with TB service (45 days vs. 26 days; p < 0.01) and decrease in median time between first contact and diagnosis, and treatment initiation, respectively, during COVID-19 compared to before. Fewer patients reported using public health centers and more patients reporting using private facilities as the point of first contact following TB symptom onset during the COVID-19 period compared to before. These findings suggest that COVID-19 has created barriers to TB service access and health seeking among symptomatic individuals, yet also led to some efficiencies in TB diagnostic and treatment services. Our findings can be help target efforts along specific points of the TB patient pathway to minimize the overall disruption of COVID-19 and future public health emergencies on TB control in Burkina Faso.
- 9 September 2022
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 7 (9) , 237
Open AccessDelays in TB Diagnosis and Treatment Initiation in Burkina Faso during the COVID-19 Pandemic
The COVID-19 pandemic has significantly disrupted TB services, particularly in low resource settings. In Burkina Faso, a cross-sectional ‘before and after’ study was conducted to assess the impact of COVID-19 on access to TB services. Data was collected in two phases (Phase 1: December 2017–March 2018, and 2: October–December 2020) to estimate and compare various patient and system delays among TB patients before and during COVID-19 and explore changes in treatment seeking behaviors and practices. 331 TB patients were recruited across the two phases. A significant increase in median time between first symptom and contact with TB service (45 days vs. 26 days; p < 0.01) and decrease in median time between first contact and diagnosis, and treatment initiation, respectively, during COVID-19 compared to before. Fewer patients reported using public health centers and more patients reporting using private facilities as the point of first contact following TB symptom onset during the COVID-19 period compared to before. These findings suggest that COVID-19 has created barriers to TB service access and health seeking among symptomatic individuals, yet also led to some efficiencies in TB diagnostic and treatment services. Our findings can be help target efforts along specific points of the TB patient pathway to minimize the overall disruption of COVID-19 and future public health emergencies on TB control in Burkina Faso.